[ATRC] AtriCure, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Medical/Dental Instruments

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 19.23 Change: 0.41 (2.15%)
Ext. hours: Change: 0 (0%)

chart ATRC

Refresh chart

Strongest Trends Summary For ATRC

ATRC is in the medium-term up 11% in 1 month. In the long-term up 73% above S&P in 1 year and up 103% in 4 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: AtriCure, Inc., a medical device company, provides atrial fibrillation solutions worldwide. It provides isolator bipolar radio-frequency (RF) ablation clamps that are used for ablation during open-heart procedures; and ablation and sensing unit, a compact power generator that provides the RF energy for its clamps, multifunctional pens, and coolrail linear ablation devices. The company also offers AtriCure Switch Box, a compact switch box, which offers the technology needed for the dual pulsing electrodes in isolator synergy clamps; isolator multifunctional pens that enable surgeons to evaluate cardiac arrhythmias, as well as to perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and coolrail linear ablation device, a disposable linear RF ablation device that allows physicians to create an expanded cardiac ablation lesion set during minimally invasive procedures. In addition, it provides RF ablation devices, such as COBRA Fusion Surgical Ablation System; C

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding EPS-1.06 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 12.72% Sales Growth - Q/Q1.6% P/E-20.6
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-8.97% ROE-10.71% ROI-10.69%
Current Ratio3.79 Quick Ratio3.18 Long Term Debt/Equity Debt Ratio0.19
Gross Margin70.96% Operating Margin-12.07% Net Profit Margin-12.24% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities1.82 M Cash From Investing Activities2.56 M Cash From Operating Activities-8.97 M Gross Profit21.73 M
Net Profit-5.27 M Operating Profit-5.14 M Total Assets153.41 M Total Current Assets93.42 M
Total Current Liabilities24.63 M Total Debt6.08 M Total Liabilities24.85 M Total Revenue29.89 M
Technical Data
High 52 week35.58 Low 52 week15.52 Last close32.91 Last change-0.87%
RSI68.11 Average true range0.91 Beta0.63 Volume87.66 K
Simple moving average 20 days3.79% Simple moving average 50 days7.53% Simple moving average 200 days8.88%
Performance Data
Performance Week-0.84% Performance Month5.35% Performance Quart4.98% Performance Half0%
Performance Year81.02% Performance Year-to-date7.55% Volatility daily1.85% Volatility weekly4.13%
Volatility monthly8.47% Volatility yearly29.33% Relative Volume226.41% Average Volume201.47 K
New High New Low

News

2019-03-05 07:40:00 | Factors of Influence in 2019, Key Indicators and Opportunity within Expedia Group, Lumentum, Patterson Companies, Allscripts Healthcare Solutions, AtriCure, and Biohaven Pharmaceutical Holding — New Research Emphasizes Economic Growth

2019-03-02 00:48:11 | AtriCure Inc ATRC Files 10-K for the Fiscal Year Ended on December 31, 2018

2019-03-01 06:53:53 | Edited Transcript of ATRC earnings conference call or presentation 28-Feb-19 9:30pm GMT

2019-02-28 21:50:31 | AtriCure Inc ATRC Q4 2018 Earnings Conference Call Transcript

2019-02-28 16:02:00 | AtriCure Reports Fourth Quarter and Full Year 2018 Financial Results

2019-02-25 20:38:41 | Mason firm to add 100-plus jobs in $15M expansion

2019-02-21 10:31:03 | Analysts Estimate AtriCure ATRC to Report a Decline in Earnings: What to Look Out for

2019-02-19 08:00:00 | AtriCure Announces The Society of Thoracic Surgeons Has Endorsed the Company’s Advanced Ablation Courses in the United States

2019-02-12 08:00:00 | AtriCure Announces Launch of the cryoICE® cryoSPHERE™ Probe

2019-02-05 08:00:00 | AtriCure Announces the First Patient Enrolled in the ICE-AFIB™ Clinical Trial

2019-02-04 08:30:00 | AtriCure to Announce Fourth Quarter and Full Year 2018 Financial Results

2019-01-31 09:19:02 | AtriCure ATRC Upgraded to Strong Buy: Here's What You Should Know

2019-01-28 07:25:00 | Recent Analysis Shows Textron, Occidental Petroleum, AtriCure, Chegg, KBR, and V.F. Market Influences — Renewed Outlook, Key Drivers of Growth

2019-01-08 14:36:25 | Who Has Been Buying AtriCure, Inc. NASDAQ:ATRC Shares?

2019-01-08 09:56:10 | Here's how Dayton-area stocks performed in 2018

2019-01-07 08:30:00 | AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2018

2019-01-02 14:03:15 | These were the best Cincinnati stocks in 2018

2018-12-27 08:47:01 | Perrigo Stock Up as Appeal Date for Irish Tax Bill Nears

2018-12-24 10:04:03 | Perrigo Plunges on $1.9B Tax Bill From Irish Government

2018-12-13 08:00:00 | AtriCure to Present at the 37th Annual J.P. Morgan Healthcare Conference

2018-12-13 05:02:19 | Hedge Funds Are Crazy About AtriCure Inc. ATRC

2018-11-30 13:47:56 | What Kind Of Shareholders Own AtriCure Inc NASDAQ:ATRC?

2018-11-12 08:40:00 | Detailed Research: Economic Perspectives on Roku, Exelixis, Scientific Games, Boot Barn, Astronics, and AtriCure — What Drives Growth in Today's Competitive Landscape

2018-11-08 09:30:00 | AtriCure to Present at the Piper Jaffray 30th Annual Healthcare Conference

2018-11-02 00:10:22 | Edited Transcript of ATRC earnings conference call or presentation 1-Nov-18 8:30pm GMT

2018-11-01 18:35:10 | AtriCure ATRC Reports Q3 Loss, Tops Revenue Estimates

2018-11-01 17:30:31 | AtriCure: 3Q Earnings Snapshot

2018-11-01 16:01:00 | AtriCure Reports Third Quarter 2018 Financial Results

2018-10-22 16:01:00 | AtriCure to Participate in Upcoming Investor Conferences

2018-10-16 14:12:58 | Is AtriCure Inc NASDAQ:ATRC A Financially Sound Company?

2018-10-12 09:10:00 | Report: Developing Opportunities within Agree Realty, Lattice Semiconductor, American Outdoor Brands, Schneider National, AtriCure, and Universal Display — Future Expectations, Projections Moving into 2018

2018-10-11 08:00:00 | AtriCure to Announce Third Quarter 2018 Financial Results

2018-10-10 17:20:52 | These Cincinnati stocks took the biggest hit amid Dow’s worst loss since February

2018-10-08 10:04:02 | AtriCure ATRC Looks Good: Stock Adds 6.8% in Session

2018-10-05 16:29:00 | Why Chefs' Warehouse, SMART Global Holdings, and AtriCure Jumped Today

2018-10-05 08:35:11 | The Daily Biotech Pulse: MediciNova Gets Orphan-Drug Status, KemPharm To Offer Shares, Emergent Buys Vaccine Maker

2018-10-04 18:09:00 | AtriCure Announces Pricing of Public Offering of Common Stock

2018-10-04 07:59:50 | The Daily Biotech Pulse: AtriCure's Guidance, Guardant Health And Kodiak To Debut

2018-10-03 16:01:00 | AtriCure Announces Proposed Public Offering of Common Stock

2018-10-03 16:01:00 | AtriCure Reports Preliminary Financial Results for Third Quarter 2018

2018-08-28 08:00:00 | AtriCure Announces Completion of Patient Enrollment in the CONVERGE IDE Clinical Trial

2018-08-21 08:00:00 | AtriCure to Present at the Morgan Stanley Global Healthcare Conference

2018-08-08 08:25:00 | Report: Exploring Fundamental Drivers Behind BancFirst, Materion, Acuity Brands, USA Truck, Marriott International, and AtriCure — New Horizons, Emerging Trends, and Upcoming Developments

2018-08-01 19:18:45 | Edited Transcript of ATRC earnings conference call or presentation 1-Aug-18 8:30pm GMT

2018-08-01 18:45:10 | AtriCure ATRC Reports Q2 Loss, Tops Revenue Estimates

2018-08-01 17:38:30 | AtriCure: 2Q Earnings Snapshot

2018-08-01 16:01:00 | AtriCure Reports Second Quarter 2018 Financial Results

2018-07-24 16:30:00 | ViewRay Appoints Scott Drake as President, Chief Executive Officer and a Member of the Board of Directors, Shar Matin as Chief Operating Officer, and D. Keith Grossman as a Member of the Board of Directors

2018-07-20 12:50:00 | AtriCure Made an Important Upside Breakout

2018-07-16 08:00:00 | AtriCure to Present at the Canaccord Genuity 38th Annual Growth Conference